Root Coverage Using a Xenograph for Treatment of Gingival Recession

July 21, 2017 updated by: Daniel Assad, Mayo Clinic

PriMatrix Utilization to Achieve Dental Root Coverage

Can a fetal bovine derived membrane serve as an alternative to autogenous tissue for dental root coverage procedures.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

PriMatrix (TEI Medical Inc) is a promising collagen membrane derived from fetal bovine dermis. The acellular porous structure of the membrane permits rapid re-vascularization and cellular re-population. The membrane contains a high proportion of type III collagen. Type III collagen helps regulate tissue healing by promoting neoepithelialization and angiogenesis. Wounds grafted with PriMatrix exhibited significantly faster healing rates compared to control wounds while having a minimal foreign body response and early repopulation by progenitor cells.

The ability of PriMatrix to permit neovascularization, reepithelialization, minimal immune response, and population by progenitor cells suggests that it may serve as an ideal alternative to CTG under CPF for root coverage. In this regard, the current study aims to serve as a pilot to test the feasibility of the use of PriMatrix as a graft material under a CPF to attain root coverage of Miller Class I & II defects.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

  • Inclusion Criteria:

    • Adults 18-90 years of age
    • Miller Class I & II defects on maxillary or mandibular teeth
    • At least 1 adjacent non-involved tooth on either side of the included recession defects
    • Keratinized tissue width of ≥2.0 mm
    • Periodontal probing depths of 3 mm or on included teeth
    • Plaque index of 2 or less
    • Bleeding on probing at 30% or less sites
    • Current non-smoker
    • No active infected wounds
  • Exclusion Criteria

    • Patients less than 18 years of age
    • Miller Class III, or IV mucogingival defects
    • Miller Class I & II defects without adjacent non-involved teeth
    • CEJ not identifiable
    • Root surface restoration at the defect site
    • Periodontal probing depths greater than 3 mm
    • Plaque index of 2 or greater
    • Bleeding on probing at more than 30% of sites
    • Uncontrolled oral disease
    • Moderate to severe generalized chronic or aggressive periodontitis
    • Oral manifestations of a systemic disease
    • History of previous root coverage procedure, graft, or GTR
    • Current smoker or other tobacco use
    • Alcohol abuse problems
    • Traumatic occlusion impinging on the recession defect
    • Use of intraoral appliances that impinge on the recession defect
    • Intra-oral piercings that impinge on the included defect
    • Uncontrolled systemic health conditions
    • Debilitating systemic or infectious disease
    • Diabetes
    • Heart Disease
    • Uncontrolled heart disease
    • Delayed wound healing
    • Immunocompromised status due to medication or immune system dysfunction
    • Active infection or non-healing wounds
    • Currently pregnant or lactating
    • Long-term steroid use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PriMatrix
Use of PriMatrix as a substitute for a subepithelial connective tissue graft under a coronal positioned flap for root coverage.
Use of PriMatrix under a coronal positioned flap to obtain root coverage.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete Root Coverage
Time Frame: 6-months
The percentage of sites showing complete root coverage will be calculated as a percent of treated defects with the marginal gingival located at or above the cement-enamel junction compared to the total defects treated.
6-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Determine keratinized tissue width of the augmented region using a UNC-15 mm periodontal probe.
Baseline, 6-weeks, 4-months, and 6-months
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Determine periodontal probing depths of the augmented region using a UNC-15 mm periodontal probe.
Baseline, 6-weeks, 4-months, and 6-months
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Determine tissue thickness of the augmented region using a UNC-15 mm periodontal probe.
Baseline, 6-weeks, 4-months, and 6-months
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Determine clinical attachment levels of the augmented region using a UNC-15 mm periodontal probe.
Baseline, 6-weeks, 4-months, and 6-months
Pain Levels
Time Frame: 1-week, 2-weeks, 4-weeks, and 6-months
Visual analog scale questionnaire will be completed consisting of 5 to 6 questions at each appointment.
1-week, 2-weeks, 4-weeks, and 6-months
Mean Root Coverage Obtained
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Percentage of baseline root coverage obtained as a fraction of initial recession depth will be measured using a UNC-15 mm periodontal probe.
Baseline, 6-weeks, 4-months, and 6-months
Gingival Health
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Gingival health will be evaluated visually using Silness and Loe Gingival index.
Baseline, 6-weeks, 4-months, and 6-months
Plaque Levels
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
Plaque levels will be evaluated using the Quigley and Hein plaque index.
Baseline, 6-weeks, 4-months, and 6-months
Esthetic Outcomes
Time Frame: 1-week, 2-weeks, 4-weeks, and 6-months
Visual analog scale questionnaire will be completed consisting of 5 to 6 questions at each appointment.
1-week, 2-weeks, 4-weeks, and 6-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Daniel Assad, DDS, Mayo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

December 16, 2015

First Submitted That Met QC Criteria

January 13, 2016

First Posted (Estimate)

January 15, 2016

Study Record Updates

Last Update Posted (Actual)

July 25, 2017

Last Update Submitted That Met QC Criteria

July 21, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Localized Gingival Recession

Clinical Trials on PriMatrix

Subscribe